IQVIA Holdings | IQV - PE Price to Earnings


IQVIA Holdings reported 21.45 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Accenture 13.39 1.89 Mar/2026
Agilent 23.66 3.13 Jun/2026
Bruker 46.54 9.74 Jun/2026
Cardinal Health 26.16 4.24 Jun/2026
Celltrion 58.97 8.86 Mar/2026
Charles River Laboratories 58.27 29 Jun/2026
Cigna 11.69 0.34 Jun/2026
Cognizant Technology Solutions 6.88 4.47 Jun/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
CVS Health 12.51 2.86 Jun/2026
Danaher 32.68 3.4 Jun/2026
Dentsply International 20.31 9.68 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Elevance Health 17.11 4.71 Jun/2026
Humana 24.28 13.21 Jun/2026
IBM 24.1 5.96 Mar/2026
Illumina 48.98 16.53 Jun/2026
Infosys 16.92 7.23 Mar/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Laboratory Of America 20.47 5.04 Jun/2026
Malin Corporation 11.81 0.72 Jun/2023
McKesson 20.36 4.61 Jun/2026
Mettler Toledo International 27.29 0.04 Jun/2026
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 16.35 2.78 Jun/2026
Publicis 11.94 0.89 Jun/2026
Qiagen NV 16.72 2.76 Jun/2026
Quest Diagnostics 21.23 1.17 Jun/2026
Revvity 36.47 5.68 Jun/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Thermo Fisher Scientific 26.4 1.31 Jun/2026
Tilray 11.56 80.19 Sep/2025
UnitedHealth 20.96 5.68 Jun/2026
Veeva Systems 33.41 6.64 Jun/2026
Veradigm 11.15 4.63 Sep/2022
Waters 66.69 36.94 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026